2 Einträge |
Seite 1 / 1
![]() |
Early clinical outcomes as a function of use of newer oral P2Y12 inhibitors versus clopidogrel in the EUROMAX trial. |
Huber K, Ducrocq G, Hamm CW, van 't Hof A, Lapostolle F, Coste P, Gordini G, Steinmetz J, Verheugt FWA, Adgey J, Nibbe L, Kaniĉ V, Clemmensen P, Zeymer U, Bernstein D, Prats J, Deliargyris EN, Gabriel Steg P |
Open heart. 2017 Nov 28. doi: 10.1136/openhrt-2017-000677. pii: openhrt-2017-000677. pmc: PMC5708315 |
PMID: 29225903 |
Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study. |
Bagai A, Goodman SG, Cantor WJ, Vicaut E, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Merkely B, Storey RF, Ten Berg JM, Zeymer U, Diallo A, Hamm CW, Tsatsaris A, El Khoury J, Van't Hof AW, Montalescot G |
American heart journal. 2017 Nov 4. pii: S0002-8703(17)30351-4. doi: 10.1016/j.ahj.2017.10.021 |
PMID: 29421015 |
2 Einträge |
Seite 1 / 1
![]() |